Is Late Recurrence a Predictive Clinical Marker for Better Sunitinib Response in Metastatic Renal Cell Carcinoma Patients?-Reference-Cited by-同舟云学术

Is Late Recurrence a Predictive Clinical Marker for Better Sunitinib Response in Metastatic Renal Cell Carcinoma Patients?

Published:2015-12 Issue:6 Volume:13 Page:548-554
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Bozkurt Oktay,Hacıbekiroglu Ilhan,Kaplan Muhammet Ali,Duzkopru Yakup,Uysal Mukremin,Karaca Halit,Berk Veli,Inanc Mevlude,Duran Ayse Ocak,Ozaslan Ersin,Ucar Mahmut,Ozkan Metin

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference27 articles.

1. Renal cell carcinoma;Cohen;N Engl J Med,2005

2. Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma;Hotmann;Eur Urol,2005

3. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease;Janzen;Urol Clin North Am,2003

4. Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal cell carcinoma. Groupe Français d'Immunothérapie;Negrier;N Engl J Med,1998

5. Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma;Motzer;J Clin Oncol,2006

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-Effectiveness of Nivolumab Plus Ipilimumab for the First-Line Treatment of Intermediate/Poor-Risk Advanced and/or Metastatic Renal Cell Carcinoma in Switzerland;PharmacoEconomics - Open;2023-02-09

2. Albumin levels predict prognosis in advanced renal cell carcinoma treated with tyrosine kinase inhibitors: a systematic review and meta-analysis;Urologic Oncology: Seminars and Original Investigations;2022-01

3. Novel cut‐off values of time from diagnosis to systematic therapy predict the overall survival and the efficacy of targeted therapy in renal cell carcinoma: A long‐term, follow‐up, retrospective study;International Journal of Urology;2021-11-30

4. Targeted therapy response in early versus late recurrence of renal cell carcinoma after surgical treatment: A propensity score‐matched study using the Korean Renal Cancer Study Group database;International Journal of Urology;2021-02

5. The clinical significance of routine risk categorization in metastatic renal cell carcinoma and its impact on treatment decision-making: a systematic review;Future Oncology;2020-12